The relevance of synuclein autoantibodies as a biomarker for Parkinson's disease
2022 | journal article; research paper. A publication with affiliation to the University of Göttingen.
Jump to:Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Garg, P., Maass, F., Sundaram, S. M., Mollenhauer, B., Mahajani, S., van Riesen, C., Kügler, S. ... Bähr, M. (2022). The relevance of synuclein autoantibodies as a biomarker for Parkinson's disease. Molecular and Cellular Neuroscience, 121, Article 103746. doi: https://doi.org/10.1016/j.mcn.2022.103746
Documents & Media
Details
- Authors
- Garg, Pretty; Maass, Fabian; Sundaram, Sivaraj M.; Mollenhauer, Brit; Mahajani, Sameehan; van Riesen, Christoph; Kügler, Sebastian; Bähr, Mathias
- Issue Date
- 2022
- Journal
- Molecular and Cellular Neuroscience
- Project
- EXC 2067: Multiscale Bioimaging
- Working Group
- RG Bähr (Neurobiological Research Laboratory)
- External URL
- https://mbexc.uni-goettingen.de/literature/publications/496
- ISSN
- 1044-7431
- Language
- English
